# GI View

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gi-view

- Industry: Medical Devices & Equipment
- Headquarters: Ramat Gan, Israel
- Website: www.giview.com
- Total disclosed funding: $10M
- Latest round: Series C (Apr 5, 2006)
- Investors on record: 2

## About

GI View Ltd. is a medical technology company that specializes in the development of innovative single-use colonoscopes, aiming to enhance GI endoscopic procedures while prioritizing patient safety and hygiene.Founded in 2004 in Ramat Gan, Israel, GI View Ltd. focuses on developing advanced colonoscopy technologies. The company has successfully completed 8 deals, with its most recent deal in December 2014, raising USD 13.00 mn from undisclosed investors. The company operates independently and has not undergone any significant pivots or mergers since its establishment. The founder's history is not detailed, but the company continues to expand its impact in the field of gastroenterology.GI-View specializes in the development and distribution of single-use colonoscopes, particularly their flagship product, the SoloScope. This device enhances gastrointestinal endoscopic procedures by eliminating risks associated with disease transmission, featuring a 200° field of view for improved visualization. Targeted primarily at healthcare facilities, GI-View's products cater to hospitals and medical centers focused on gastroenterology, aligning with the increasing demand for advanced, hygienic endoscopy solutions across international markets, including North America, Europe, and select regions in Asia.GI-View generates revenue through direct sales of its single-use colonoscopes to healthcare providers, including hospitals and outpatient clinics specializing in gastroenterology. The company adopts a B2B transactional structure for bulk orders, emphasizing the importance of hygiene in GI diagnostics. Payments for these products are typically made upfront, reflecting the value of the SoloScope's innovative design, which meets diverse client needs while ensuring a reliable supply of endoscopy solutions.GI View Ltd. plans to leverage the USD 13.00 mn raised in December 2014 to further its growth initiatives. The company aims to design and launch new products to enhance its portfolio, with a focus on expanding into additional international markets by 2025. GI View is particularly targeting regions in Asia and Europe to broaden its reach and capitalize on the increasing demand for single-use medical devices.

## Funding rounds

- Series C, Apr 5, 2006, $10M — Delta Ventures, Israel Healthcare Ventures

## Investors

- Delta Ventures (https://capitalatlas.ai/funds/delta-ventures) — Series C
- Israel Healthcare Ventures (https://capitalatlas.ai/funds/israel-healthcare-ventures) — Series C